Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Theratechnologies Inc (NASDAQ: THTX) closed at $3.25 in the last session, up 0.15% from day before closing price of $3.24. In other words, the price has increased by $0.15 from its previous closing price. On the day, 0.94 million shares were traded. THTX stock price reached its highest trading level at $3.26 during the session, while it also had its lowest trading level at $3.23.
Ratios:
We take a closer look at THTX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.32. For the most recent quarter (mrq), Quick Ratio is recorded 0.65 and its Current Ratio is at 0.84.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on November 17, 2022, initiated with a Overweight rating and assigned the stock a target price of $9.
On July 29, 2021, Canaccord Genuity Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $8 to $3.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THTX now has a Market Capitalization of 150120752 and an Enterprise Value of 183135056. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.77. Its current Enterprise Value per Revenue stands at 2.17 whereas that against EBITDA is 20.942.
Stock Price History:
The Beta on a monthly basis for THTX is 0.51, which has changed by 1.443609 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, THTX has reached a high of $3.25, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is 10.01%, while the 200-Day Moving Average is calculated to be 52.56%.
Shares Statistics:
According to the various share statistics, THTX traded on average about 480.43K shares per day over the past 3-months and 341870 shares per day over the past 10 days. A total of 45.98M shares are outstanding, with a floating share count of 36.33M. Insiders hold about 20.99% of the company’s shares, while institutions hold 26.27% stake in the company. Shares short for THTX as of 1753920000 were 228413 with a Short Ratio of 0.48, compared to 1751241600 on 218473. Therefore, it implies a Short% of Shares Outstanding of 228413 and a Short% of Float of 0.73.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of Theratechnologies Inc (THTX) in the stock market.The consensus estimate for the next quarter is $0.04, with high estimates of $0.04 and low estimates of $0.04.
Analysts are recommending an EPS of between $0.04 and -$0.24 for the fiscal current year, implying an average EPS of -$0.1. EPS for the following year is $0.19, with 3.0 analysts recommending between $0.29 and $0.11.
Revenue Estimates
According to 1 analysts, the current quarter’s revenue is expected to be $26.89M. It ranges from a high estimate of $26.89M to a low estimate of $26.89M. As of the current estimate, Theratechnologies Inc’s year-ago sales were $30.92MFor the next quarter, 1 analysts are estimating revenue of $30.12M. There is a high estimate of $30.12M for the next quarter, whereas the lowest estimate is $30.12M.
A total of 1 analysts have provided revenue estimates for THTX’s current fiscal year. The highest revenue estimate was $107.41M, while the lowest revenue estimate was $107.41M, resulting in an average revenue estimate of $107.41M. In the same quarter a year ago, actual revenue was $122.84MBased on 3 analysts’ estimates, the company’s revenue will be $127.37M in the next fiscal year. The high estimate is $130.53M and the low estimate is $121.65M.
